MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-31-2026
Xtant Medical Holdings Total Assets 2011-2026 | XTNT
Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.Main categories of assets
Current assets (used within one year):
- Cash and cash equivalents
- Accounts receivable (amounts owed by customers)
- Inventory of goods, raw materials, and supplies
- Short-term investments
- Fixed assets (buildings, machinery, equipment)
- Intangible assets (brands, patents, software)
- Long-term investments
- Goodwill (reputational value from mergers)
Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.
Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.
Annual Total Assets Xtant Medical Holdings
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 94.1 M | 93.8 M | 92.6 M | 60.2 M | 54.7 M | 41.5 M | 43.2 M | 46.4 M | 106 M | 144 M | 143 M | 28 M | 28.9 M | 34.5 M | 23.2 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 144 M | 23.2 M | 68.9 M |
Quarterly Total Assets Xtant Medical Holdings
| 2025-Q3 | 2025-Q2 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 106 M | 103 M | 93.8 M | 98.9 M | 95.6 M | 93.9 M | 92.6 M | 92 M | 65.2 M | 63.3 M | 60.2 M | 56 M | - | 53.2 M | 54.7 M | 55.8 M | 59.7 M | 58.7 M | 41.5 M | 41.5 M | 41.5 M | 41.5 M | 43.2 M | 43.2 M | 43.2 M | 43.2 M | 46.4 M | 46.4 M | 46.4 M | 46.4 M | 106 M | 106 M | 106 M | 106 M | 144 M | 144 M | 144 M | 144 M | 141 M | 141 M | 141 M | 141 M | 28 M | 28 M | 28 M | 28 M | 28.9 M | 28.9 M | 28.9 M | 28.9 M | 34.5 M | 34.5 M | 34.5 M | 34.5 M | 23.2 M | 23.2 M | 23.2 M | 23.2 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 144 M | 23.2 M | 67.5 M |
Total Assets of other stocks in the Medical devices industry
| Issuer | Total Assets | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
GenMark Diagnostics, Inc.
GNMK
|
224 M | - | - | $ 1.77 B |  USA |
 |
Apollo Endosurgery
APEN
|
110 M | - | - | $ 475 M | USA |
 |
Acutus Medical
AFIB
|
54 M | - | -26.83 % | $ 2.62 M | USA |
 |
Avinger
AVGR
|
13.8 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
659 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
62.4 M | - | 1.37 % | $ 20.5 M | USA |
 |
Allied Healthcare Products
AHPI
|
19.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
10.6 M | - | -5.86 % | $ 30.6 M | USA |
 |
BioSig Technologies
BSGM
|
188 M | - | 37.08 % | $ 85.7 M | USA |
 |
Cardiovascular Systems
CSII
|
323 M | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
346 M | - | -10.19 % | $ 1.99 M | USA |
 |
CryoLife, Inc.
CRY
|
789 M | - | -4.14 % | $ 702 M | USA |
 |
Dynatronics Corporation
DYNT
|
15.4 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
132 M | - | - | $ 10.2 M | USA |
 |
Abbott Laboratories
ABT
|
86.7 B | $ 102.58 | -0.28 % | $ 179 B | USA |
 |
Soliton, Inc.
SOLY
|
33.8 M | - | -1.42 % | $ 435 M | USA |
 |
Conformis
CFMS
|
94 M | - | - | $ 16.4 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
10.5 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
64.1 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
204 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
66.2 M | - | - | $ 111 M |  Canada |
 |
Second Sight Medical Products
EYES
|
39.4 M | - | -0.97 % | $ 54.4 M | USA |
 |
Intersect ENT, Inc.
XENT
|
227 M | - | - | $ 955 M | USA |
 |
BIOLASE
BIOL
|
35.1 M | - | -13.19 % | $ 166 K | USA |
 |
AdaptHealth Corp.
AHCO
|
4.32 B | $ 12.17 | 1.16 % | $ 1.64 B | USA |
 |
Invacare Corporation
IVC
|
771 M | - | - | $ 24.7 M | USA |
 |
Align Technology
ALGN
|
6.21 B | $ 172.16 | 0.91 % | $ 12.9 B | USA |
 |
Apyx Medical Corporation
APYX
|
66.8 M | $ 3.88 | 5.43 % | $ 159 M | USA |
 |
Alphatec Holdings
ATEC
|
791 M | $ 10.93 | 0.92 % | $ 1.64 B | USA |
 |
AxoGen
AXGN
|
222 M | $ 33.66 | -2.26 % | $ 1.55 B | USA |
 |
Butterfly Network
BFLY
|
256 M | $ 4.1 | -0.36 % | $ 868 M | USA |
 |
Bruker Corporation
BRKR
|
5.81 B | $ 36.75 | -0.03 % | $ 5.48 K | USA |
 |
Boston Scientific Corporation
BSX
|
43.7 B | $ 63.21 | 0.62 % | $ 93.6 B | USA |
 |
ClearPoint Neuro
CLPT
|
97.7 M | $ 9.53 | 1.71 % | $ 270 M | USA |
 |
CONMED Corporation
CNMD
|
2.33 B | $ 34.78 | -0.03 % | $ 1.08 B | USA |
 |
Cytosorbents Corporation
CTSO
|
44.2 M | $ 0.6 | 2.92 % | $ 37.3 M | USA |
 |
Delcath Systems
DCTH
|
124 M | $ 9.72 | 0.88 % | $ 348 M | USA |
 |
EDAP TMS S.A.
EDAP
|
91.5 M | $ 3.56 | 5.0 % | $ 133 M |  France |
 |
Electromed
ELMD
|
53.8 M | $ 23.59 | 1.29 % | $ 199 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
13.7 B | $ 81.57 | 0.64 % | $ 47.7 B | USA |
 |
FONAR Corporation
FONR
|
199 M | $ 18.56 | -0.16 % | $ 122 M | USA |
 |
NanoVibronix
NAOV
|
3.63 M | - | - | $ 1.08 M | USA |
 |
Globus Medical
GMED
|
5.3 B | $ 87.65 | -0.31 % | $ 11.9 B | USA |
 |
Helius Medical Technologies
HSDT
|
7.69 M | $ 1.97 | 5.65 % | $ 1.2 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
4.04 B | $ 9.4 | -1.36 % | $ 724 M | USA |
 |
Inogen
INGN
|
299 M | $ 6.46 | 4.03 % | $ 172 M | USA |
 |
Inspire Medical Systems
INSP
|
907 M | $ 56.86 | 3.4 % | $ 1.67 B | USA |
 |
IRIDEX Corporation
IRIX
|
29.2 M | $ 1.01 | 3.09 % | $ 17.1 M | USA |